CBSA: 2013 was successful year for state's bioscience sector

CBSA: 2013 was successful year for state's bioscience sector

DENVER - Colorado bioscience companies realized a number of key financings and acquisitions in 2013, according to the Colorado BioScience Association , an industry support group. "We saw... Read More

By: InnovatioNews Wednesday December 18, 2013 0 comments Tags: April Giles, Biodesix, Clovis Oncology, Denver, Gambro BCT, Inviragen, Lanx, SomaLogic, Surefire Medical

Inviragen to be acquired by Takeda Pharmaceutical for up to $250 million

Inviragen to be acquired by Takeda Pharmaceutical for up to $250 million

FORT COLLINS - Inviragen Inc . will be acquired by Osaka, Japan-based Takeda Pharmaceutical Company Ltd. for an upfront cash payment of $35 million and future payments of up to $215 million linked... Read More

By: Steve Wednesday May 8, 2013 0 comments Tags: DENVax, Dr. Dan Stinchcomb, Fort Collins, Inviragen

Inviragen advances DENVax into second stage of Phase 2 clinical study

Inviragen advances DENVax into second stage of Phase 2 clinical study

FORT COLLINS - Inviragen Inc. today announced the start of the second stage of an ongoing Phase 2, randomized, double-blind, placebo-controlled study of DENVax, the company's investigational... Read More

By: Steve Wednesday February 27, 2013 0 comments Tags: DENVax, Dr. Dan Stinchcomb, Fort Collins, Inviragen

Inviragen's JE technology licensed to Viet firm

Inviragen's JE technology licensed to Viet firm

FORT COLLINS - Inviragen will license its proprietary Japanese Encephalitis (JE) technology to Hanoi, Vietnam-based The Company for Vaccine and Biological Production (VABIOTECH) to produce a... Read More

By: Steve Thursday January 3, 2013 0 comments Tags: Dr. Dan Stinchcomb, Fort Collins, Inviragen

Inviragen and International Vaccine Institute expand dengue impact partnership

Inviragen and International Vaccine Institute expand dengue impact partnership

FORT COLLINS - Under an existing Memorandum of Understanding, Inviragen and the International Vaccine Institute announced a collaboration to assess the total health impact of dengue fever cases... Read More

By: Steve Thursday November 8, 2012 0 comments Tags: dengue fever, Dr. Dan Stinchcomb, Fort Collins, Inviragen

Inviragen's Hand, Foot & Mouth vaccine  ready for larger trial

Inviragen's Hand, Foot & Mouth vaccine ready for larger trial

More than 2 million children may be spared disease annually By Betsy Lynch InnovatioNews.com FORT COLLINS -- Hand, foot and mouth disease (HFMD) doesn't get much press in Colorado. Yet... Read More

By: Betsy Lynch Wednesday May 30, 2012 0 comments Tags: Dr. Dan Stinchcomb, Dr. Tambyah, HFMD, Inviragen, Science